StockNews.com cut shares of Ultralife (NASDAQ:ULBI – Free Report) from a strong-buy rating to a buy rating in a report issued on Tuesday morning. Separately, Benchmark raised their price objective on shares of Ultralife from $12.00 to $13.00 and gave the stock a buy rating in a report on Tuesday, March 5th. Check Out Our […]